BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 15752977)

  • 1. Tumor cells caught in the act of invading: their strategy for enhanced cell motility.
    Wang W; Goswami S; Sahai E; Wyckoff JB; Segall JE; Condeelis JS
    Trends Cell Biol; 2005 Mar; 15(3):138-45. PubMed ID: 15752977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The great escape: when cancer cells hijack the genes for chemotaxis and motility.
    Condeelis J; Singer RH; Segall JE
    Annu Rev Cell Dev Biol; 2005; 21():695-718. PubMed ID: 16212512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coordinated regulation of pathways for enhanced cell motility and chemotaxis is conserved in rat and mouse mammary tumors.
    Wang W; Wyckoff JB; Goswami S; Wang Y; Sidani M; Segall JE; Condeelis JS
    Cancer Res; 2007 Apr; 67(8):3505-11. PubMed ID: 17440055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis.
    Condeelis J; Pollard JW
    Cell; 2006 Jan; 124(2):263-6. PubMed ID: 16439202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HOXD3 enhances motility and invasiveness through the TGF-beta-dependent and -independent pathways in A549 cells.
    Miyazaki YJ; Hamada J; Tada M; Furuuchi K; Takahashi Y; Kondo S; Katoh H; Moriuchi T
    Oncogene; 2002 Jan; 21(5):798-808. PubMed ID: 11850808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Motility cues in the tumor microenvironment.
    Quaranta V
    Differentiation; 2002 Dec; 70(9-10):590-8. PubMed ID: 12492500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RBM5/H37 tumor suppressor, located at the lung cancer hot spot 3p21.3, alters expression of genes involved in metastasis.
    Oh JJ; Taschereau EO; Koegel AK; Ginther CL; Rotow JK; Isfahani KZ; Slamon DJ
    Lung Cancer; 2010 Dec; 70(3):253-62. PubMed ID: 20338664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single cell behavior in metastatic primary mammary tumors correlated with gene expression patterns revealed by molecular profiling.
    Wang W; Wyckoff JB; Frohlich VC; Oleynikov Y; Hüttelmaier S; Zavadil J; Cermak L; Bottinger EP; Singer RH; White JG; Segall JE; Condeelis JS
    Cancer Res; 2002 Nov; 62(21):6278-88. PubMed ID: 12414658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The biological role and regulation of versican levels in cancer.
    Ricciardelli C; Sakko AJ; Ween MP; Russell DL; Horsfall DJ
    Cancer Metastasis Rev; 2009 Jun; 28(1-2):233-45. PubMed ID: 19160015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of matrix metalloproteinases (MMPs) in primary human breast cancer: MMP-9 as a potential biomarker for cancer invasion and metastasis.
    Merdad A; Karim S; Schulten HJ; Dallol A; Buhmeida A; Al-Thubaity F; Gari MA; Chaudhary AG; Abuzenadah AM; Al-Qahtani MH
    Anticancer Res; 2014 Mar; 34(3):1355-66. PubMed ID: 24596383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular mechanobiology and cancer metastasis.
    Makale M
    Birth Defects Res C Embryo Today; 2007 Dec; 81(4):329-43. PubMed ID: 18228263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of human cancer cell motility and invasiveness by anaphylatoxin C5a via aberrantly expressed C5a receptor (CD88).
    Nitta H; Wada Y; Kawano Y; Murakami Y; Irie A; Taniguchi K; Kikuchi K; Yamada G; Suzuki K; Honda J; Wilson-Morifuji M; Araki N; Eto M; Baba H; Imamura T
    Clin Cancer Res; 2013 Apr; 19(8):2004-13. PubMed ID: 23287562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastasis-associated differences in gene expression in a murine model of osteosarcoma.
    Khanna C; Khan J; Nguyen P; Prehn J; Caylor J; Yeung C; Trepel J; Meltzer P; Helman L
    Cancer Res; 2001 May; 61(9):3750-9. PubMed ID: 11325848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms of metastasis.
    Weber GF
    Cancer Lett; 2008 Nov; 270(2):181-90. PubMed ID: 18522865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FMNL2 is a positive regulator of cell motility and metastasis in colorectal carcinoma.
    Zhu XL; Zeng YF; Guan J; Li YF; Deng YJ; Bian XW; Ding YQ; Liang L
    J Pathol; 2011 Jul; 224(3):377-88. PubMed ID: 21506128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid chemokinetic movement and the invasive potential of lung cancer cells; a functional molecular study.
    Tchou-Wong KM; Fok SY; Rubin JS; Pixley F; Condeelis J; Braet F; Rom W; Soon LL
    BMC Cancer; 2006 Jun; 6():151. PubMed ID: 16756685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell migration in tumors.
    Yamaguchi H; Wyckoff J; Condeelis J
    Curr Opin Cell Biol; 2005 Oct; 17(5):559-64. PubMed ID: 16098726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation-enhanced cell migration/invasion process: a review.
    Moncharmont C; Levy A; Guy JB; Falk AT; Guilbert M; Trone JC; Alphonse G; Gilormini M; Ardail D; Toillon RA; Rodriguez-Lafrasse C; Magné N
    Crit Rev Oncol Hematol; 2014 Nov; 92(2):133-42. PubMed ID: 24908570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial-mesenchymal transition and the invasive potential of tumors.
    Gavert N; Ben-Ze'ev A
    Trends Mol Med; 2008 May; 14(5):199-209. PubMed ID: 18406208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.